Avelos Therapeutics Inc. has patented new seleno-fused hetero ring DNA polymerase θ (POLθ) inhibitors potentially useful for the treatment of cancer.
Avelos Therapeutics Inc. has patented new seleno-fused hetero ring DNA polymerase θ (POLθ) inhibitors potentially useful for the treatment of cancer.